Muc17 protects intestinal epithelial cells from enteroinvasive E. coli infection by promoting epithelial barrier integrity

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 300, Issue 6, 2011, Pages

  Resta Lenert, Silvia ^a   Das, Srustidhar ^b   Batra, Surinder K ^b   Ho, Samuel B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Enteropathogens; Inflammatory bowel diseases; Mucins; Mucosal barrier

Indexed keywords

CYCLOOXYGENASE 2; MUCIN; MUCIN 17; MUCIN 3; NITRIC OXIDE SYNTHASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM ADHERENCE; CONTROLLED STUDY; ELECTRIC RESISTANCE; ELECTROPORATION; ENTEROINVASIVE ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; EXPRESSION VECTOR; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; INTESTINE MUCOSA; MEMBRANE PERMEABILITY; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; TIGHT JUNCTION;

ANALYSIS OF VARIANCE; BACTERIAL ADHESION; BACTERIAL TRANSLOCATION; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CYTOPROTECTION; ELECTRIC IMPEDANCE; ELECTROPORATION; EPITHELIAL CELLS; ESCHERICHIA COLI; HT29 CELLS; HUMANS; INTESTINAL MUCOSA; MUCINS; MUTATION; PERMEABILITY; RECOMBINANT PROTEINS; RNA INTERFERENCE; TIGHT JUNCTIONS; TIME FACTORS; TRANSFECTION;

EID: 79957939673     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00138.2010     Document Type: Article

References (60)

1. An G, Wei B, Xia B, McDaniel JM, Ju T, Cummings RD, Braun J, Xia L. Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans. J Exp Med 204: 1417-1429. 2007.
2. Andrianifahanana M, Moniaux N, Batra SK. Regulation of mucin expression: mechanistic aspects and implications for cancer and inflammatory diseases. Biochim Biophys Acta 1765: 189-222, 2006.
3. Caballero-Franco C, Keller K, DeSimone C, Chadee K. The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol 292: G315-G322, 2007.
4. Carraway K, Fregien N, Carraway-3d K, Carraway C. Tumor sialomucin complexes as tumor antigens and modulators of cellular interactions and proliferation. J Cell Sci 103: 299-307, 1992.
5. Carraway KL, Ramsauer VP, Haq B, Carothers Carraway CA. Cell signaling through membrane mucins. Bioessays 25: 66-71, 2002.
6. Chang SY, Dohrman AF, Basbaum CB, Ho SB, Toribara NW, Gum JR, Kim YS. Localization of mucin (MUC2 and MUC3) messenger RNA and peptide expression in human normal intestine and colon cancer. Gastroenterology 107: 28-36, 1994.
7. Cone RA. Barrier properties of mucus. Adv Drug Deliv Rev 61: 75-85, 2009.
8. Corazziari ES. Intestinal mucus barrier in normal and inflamed colon. J Pediatr Gastroenterol Nutr 48: 54-55, 2009.
9. Costello CM, Mah N, Hasler R, Rosenstiel P, Waetzig GH, Hahn A, Lu T, Gurbuz Y, Nikolaus S, Albrecht M, Hampe J, Lucius R, Kloppel G, Elkhoff H, Lehrach H, Lengauer T, Schreiber S. Dissection of the inflammatory bowel disease transcriptome using genome-wide Cdna microarrays. PLos Med 2: e199, 2005.
10. Dawson PA, Huxley S, Gardiner B, Tran T, McAuley GL, Grimmond S, McGuckin MA, Markovich D. Reduced mucin sulfonation and impaired intestinal barrier function in the hyposulfatemic NaS1 null mouse. Gut 58: 910-919, 2009.
11. Desseyn JL, Tetaert D, Gouyer V. Architecture of the large membranebound mucins. Gene 410: 215-222, 2008.
12. Einerhand AW, Renes IB, Makkink MK, van der Sluis M, Buller HA, Dekker J. Role of mucins in inflammatory bowel disease: important lessons from experimental models. Eur J Gastroenterol Hepatol 14: 757-765, 2002.
13. Forgue-Lafitte ME, Fabiani B, Levy PP, Maurin N, Flejou JF, Bara J. Abnormal expression of M1/MUC5AC mucin in distal colon of patients with diverticulitis, ulcerative colitis and cancer. Int J Cancer 121: 1543-1548, 2007.
14. Gibson PR, Muir JG. Reinforcing the mucus: a new therapeutic approach for ulcerative colitis? Gut 54: 900-903, 2005.
15. Gum JR Jr, Crawley SC, Hicks JW, Szymkowski DE, Kim YS. MUC17, a novel membrane-tethered mucin. Biochem Biophys Res Commun 291: 466-475, 2002.
16. Hattrup CL, Gendler SJ. Structure and function of the cell surface (tethered) mucins. Annu Rev Physiol 70: 431-457, 2008.
17. Heazlewood CK, Cook MC, Eri R, Price GR, Tauro SB, Taupin D, Thornton DJ, Png CW, Crockford TL, Cornall RJ, Adams R, Kato M, Nelms KA, Hong NA, Florin TH, Goodnow CC, McGuckin MA. Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis. PLos Med 5: e54, 2008.
18. Ho SB, Dvorak LA, Moor RE, Jacobson AC, Frey MR, Corredor J, Polk DB, Shekels LL. Cysteine-rich domains of muc3 intestinal mucin promote cell migration, inhibit apoptosis, and accelerate wound healing. Gastroenterology 131: 1501-1517, 2006.
19. Ho SB, Niehans GA, Lyftogt C, Yan PS, Cherwitz DL, Gum ET, Dahiya R, Kim YS. Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res 53: 641-651, 1993.
20. Ho SB, Shekels LL. Mucin and goblet cell function. In: Colonic Diseases, edited by Koch TR. Totowa, NJ: Humana Press, 2004, 53-72.
21. Ho SB, Luu Y, Shekels LL, Batra SK, Kandarian B, Evans DB, Zaworski PG, Wolfe CL, Heinrikson RL. Activity of recombinant cysteine-rich domain proteins derived from the membrane-bound MUC17/ Muc3 family mucins. Biochim Biophys Acta 1800: 629-638, 2010.
22. Hollingsworth MA, Swanson BJ. Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer 4: 45-60, 2004.
23. Jensen PH, Kolarich D, Packer NH. Mucin-type O-glycosylation: putting the pieces together. FEBS J 277: 81-94, 2010.
24. Jewell DP. Ulcerative colitis. In: Sleisenger and Fordtran's Gastrointestinal and Liver Disease, ed. 7, edited by Feldman M, Friedman LS, Sleisenger MH. Philadelphia, PA: WB Saunders, 2002, 2039-2067.
25. Kufe DW. Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer 9: 874-885, 2009.
26. Kyo K, Muto T, Nagawa H, Lathrop GM, Nakamura Y. Associations of distinct variants of the intestinal mucin gene MUC3A with ulcerative colitis and Crohn's disease. J Hum Genet 46: 5-20, 2001.
27. Lievin-Le Moal V, Servin AL. The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota. Clin Microbiol Rev 19: 315-337, 2006.
28. Lindén SK, Driessen KM, McGuckin MA. Improved in vitro model systems for gastrointestinal infection by choice of cell line, pH, microaerobic conditions, and optimization of culture conditions. Helicobacter 12: 341-353, 2007.
29. Linden SK, Florin TH, McGuckin MA. Mucin dynamics in intestinal bacterial infection. PLos One 3: e3952, 2008.
30. Lindén SK, Sheng YH, Every AL, Miles KM, Skoog EC, Florin TH, Sutton P, McGuckin MA. MUC1 limits Helicobacter pylori infection both by steric hindrance and by acting as a releasable decoy. PLoS Pathog 5: e1000617, 2009.
31. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 126: 1504-1517, 2004.
32. Longman RJ, Poulsom R, Corfield AP, Warren BF, Wright NA, Thomas MG. Alterations in the composition of the supramucosal defense barrier in relation to disease severity of ulcerative colitis. J Histochem Cytochem 54: 1335-1348, 2006.
33. Louis NA, Hamilton KE, Canny G, Shekels LL, Ho SB, Colgan SP. Selective induction of mucin-3 by hypoxia in intestinal epithelia. J Cell Biochem 99: 1616-1627, 2006.
34. Luu Y, Junker W, Rachagani S, Das S, Batra SK, Heinrikson RL, Shekels LL, Ho SB. Human intestinal MUC17 mucin augments intestinal cell restitution and enhances healing of experimental colitis. Int J Biochem Cell Biol 42: 996-1006, 2010.
35. Malmberg EK, Pelaseyed T, Petersson AC, Seidler UE, De Jonge H, Riordan JR, Hansson GC. The C-terminus of the transmembrane mucin MUC17 binds to the scaffold protein PDZK1 that stably localizes it to the enterocyte apical membrane in the small intestine. Biochem J 410: 283-289, 2008.
36. Melmed GY, Targan SR. Future biologic targets for IBD: potentials and pitfalls. Nat Rev Gastroenterol Hepatol 7: 110-117, 2010.
37. McAuley JL, Linden SK, Png CW, King RM, Pennington HL, Gendler SJ, Florin TH, Hill GR, Korolik V, McGuckin MA. MUC1 cell surface mucin is a critical element of the mucosal barrier to infection. J Clin Invest 117: 2313-2324, 2007.
38. McGuckin MA, Every AL, Skene CD, Linden SK, Chionh YT, Swierczak A, McAuley J, Harbour S, Kaparakis M, Ferrero R, Sutton P. Muc1 mucin limits both Helicobacter pylori colonization of the murine gastric mucosa and associated gastritis. Gastroenterology 133: 1210-1218, 2007.
39. Moehle C, Ackermann N, Langmann T, Aslanidis C, Kel A, Kel-Margoulis O, Schmitz-Madry A, Zahn A, Stremmel W, Schmitz G. Aberrant intestinal expression and allelic variants of mucin genes associated with inflammatory bowel disease. J Mol Med 84: 1055-1066, 2006.
40. Moniaux N, Junker WM, Singh AP, Jones AM, Batra SK. Characterization of human mucin MUC17. Complete coding sequence and organization. J Biol Chem 281: 23676-23685, 2006.
41. Moniaux N, Nollet S, Porchet N, Degand P, Laine A, Aubert JP. Complete sequence of the human mucin MUC4: a putative cell membraneassociated mucin. Biochem J 338: 325-333, 1999.
42. Nayeb-Hashemi H, Kaunitz JD. Gastroduodenal mucosal defense. Curr Opin Gastroenterol 25: 537-543, 2009.
43. Packey CD, Sartor RB. Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases. J Intern Med 263: 597-606, 2008.
44. Patsos G, Corfield A. Management of the mucosal defensive barrier: evidence for glycan legislation. Biol Chem 390: 581-590, 2009.
45. Poulsen LK, Lan F, Kristensen CS, Hobolth P, Molin S, Krogfelt KA. Spatial distribution of E. coli in the mouse large intestine inferred from rRNA in situ hybridization. Infect Immun 62: 5191-5194, 1994.
46. Resta-Lenert S, Barrett KE. Enteroinvasive bacteria alter barrier and transport properties of human intestinal epithelium: role of iNOS and COX-2. Gastroenterology 122: 1070-1087, 2002.
47. Resta-Lenert S, Barrett KE. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 52: 988-997, 2003.
48. Resta-Lenert S, Smitham J, Barrett KE. Epithelial dysfunction associated with the development of colitis in conventionally housed mdr1a-/- mice. Am J Physiol Gastrointest Liver Physiol 289: G153-G162, 2005.
49. Sands BE. Crohn's disease. In: Sleisenger and Fordtran's Gastrointestinal and Liver Disease, ed. 7 edited by Feldman M, Friedman LS, Sleisenger MH. Philadelphia, PA: WB Saunders, 2002, 2005-2038.
50. Satsangi J, Parkes M, Louis E. Two-stage genome-wide search in inflammatory bowel disease: evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet 14: 199-202, 1996.
51. Senapati S, Das S, Batra SK. Mucin-interacting proteins: from function to therapeutics. Trends Biochem Sci 35: 236-245, 2009.
52. Senapati S, Sharma P, Bafna S, Roy HK, Batra SK. The MUC gene family: their role in the diagnosis and prognosis of gastric cancer. Histol Histopathol 23: 1541-1552, 2008.
53. Shekels LL, Anway RE, Lin J, Lawrence CE, Garside P, Kennedy MW, Ho SB. Coordinated Muc2 and Muc3 mucin gene expression in Trichinella spiralis infection in wild-type and cytokine deficient mice. Dig Dis Sci 46: 1757-1764, 2001.
54. Shekels LL, Ho SB. Characterization of the mouse Muc3 membrane bound intestinal mucin 5'codingand promoter regions: regulation by inflammatory cytokines. Biochim Biophys Acta 1627: 90-100, 2003.
55. Shekels LL, Hunninghake DA, Tisdale AS, Gipson IK, Kieliszewsji M, Kozak CA, Ho SB. Cloning and characterization of mouse intestinal Muc3 mucin: 3'sequence contains epidermal-growth-factor-like domains. Biochem J 330: 1301-1308, 1998.
56. Stone EL, Ismail MN, Lee SH, Luu Y, Ramirez K, Haslam SM, Ho SB, Dell A, Fukuda M, Marth JD. Glycosyltransferase function in core 2-type protein O glycosylation. Mol Cell Biol 29: 3770-3782, 2009.
57. Tu QV, McGuckin MA, Mendz GL. Campylobacter jejuni response to human MUC2: modulation of colonization and pathogenicity determinants. J Med Microbiol 57: 795-802, 2008.
58. Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 9: 799-809, 2009.
59. Wang R, Katri I, Forstner J. C-terminal domain of rodent intestinal mucin Muc3 is proteolytically cleaved in the endoplasmic reticulum to generate extracellular and membrane components. Biochem J 366: 623-631, 2002.
60. Williams SJ, Wreschner DH, Tran M, Eyre HJ, Sutherland GR, McGuckin MA. Muc13, a novel human cell surface mucin expressed by epithelial and hemopoietic cells. J Biol Chem 276: 18327-18336, 2001.